tizanidine
- Product NDC
- 60760-503
- 11-digit product format
- 607600503
- Labeler code
- 60760
- Product ID
- 60760-503_7b2f41ec-06ce-4d1f-e053-2991aa0a0512
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA076533
- Marketing category
- ANDA
- Marketing start
- 2015-12-03
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-503-04 | 60760050304 | 4 TABLET in 1 BOTTLE, PLASTIC (60760-503-04) | 4 tablet | 2018-03-06 | 0000-00-00 | No | No | Current |
| 60760-503-10 | 60760050310 | 10 TABLET in 1 BOTTLE, PLASTIC (60760-503-10) | 10 tablet | 2018-03-06 | 0000-00-00 | No | No | Current |
| 60760-503-15 | 60760050315 | 15 TABLET in 1 BOTTLE, PLASTIC (60760-503-15) | 15 tablet | 2015-12-03 | 0000-00-00 | No | No | Current |
| 60760-503-30 | 60760050330 | 30 TABLET in 1 BOTTLE, PLASTIC (60760-503-30) | 30 tablet | 2017-02-15 | 0000-00-00 | No | No | Current |
| 60760-503-60 | 60760050360 | 60 TABLET in 1 BOTTLE, PLASTIC (60760-503-60) | 60 tablet | 2016-02-24 | 0000-00-00 | No | No | Current |
| 60760-503-90 | 60760050390 | 90 TABLET in 1 BOTTLE, PLASTIC (60760-503-90) | 90 tablet | 2016-04-04 | 0000-00-00 | No | No | Current |